Certified by Founder Lodge
AlgoTx
France - Suresnes, Ile-de-France
START UP
1 Disclosed Funding Rounds $21,157,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
AlgoTx develops novel solutions for complex pain. Our lead program, ATX01, targets highly prevalent Chemotherapy-Induced Peripheral Neuropathy and the orphan disease erythromelalgia.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 15 ,2023 | Series B | $21,157,000 |
Bpifrance
Omnes
UI Investissement
Turenne Groupe
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
IntelliGRC | $3,500,000 | (Mar 6, 2026)
Cyclops | $8,000,000 | (Mar 6, 2026)
NextWork | $4,450,000 | (Mar 6, 2026)
Reclaim Security | $20,000,000 | (Mar 6, 2026)
Navigara | $2,500,000 | (Mar 6, 2026)
